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Abstract
Background: During community epidemics, infections may be imported within hospital and transmitted to
hospitalized patients. Hospital outbreaks of communicable diseases have been increasingly reported during the last
decades and have had significant consequences in terms of patient morbidity, mortality, and associated costs.
Quantitative studies are thus needed to estimate the risks of communicable diseases among hospital patients,
taking into account the epidemiological process outside, hospital and host-related risk factors of infection and the
role of other patients and healthcare workers as sources of infection.
Methods: We propose a multiplicative hazard regression model to analyze the risk of acquiring a communicable
disease by patients at hospital. This model derives from epidemiological data on communicable disease epidemics
in the community, hospital ward, patient susceptibility to infection, and exposure of patients to infection at
hospital. The model estimates the relative effect of each of these factors on a patient’s risk of communicable
disease.
Results: Using individual data on patients and health care workers in a teaching hospital during the 2004-2005
influenza season in Lyon (France), we show the ability of the model to assess the risk of influenza-like illness
among hospitalized patients. The significant effects on the risk of influenza-like illness were those of old age,
exposure to infectious patients or health care workers, and a stay in a medical care unit.
Conclusions: The proposed multiplicative hazard regression model could be an interesting epidemiological tool to
quantify the risk of communicable disease at hospital during community epidemics and the uncertainty inherent in
such quantification. Furthermore, key epidemiological, environmental, host, or exposure factors that influence this
risk can be identified.
Background
Communicable diseases (CDs) such as viral respiratory
infections (e.g., influenza virus or rhinovirus infections),
viral enteric infections (e.g., hepatitis A virus or rota-
virus infections) and bacterial diseases (e.g., group A
streptococcal or meningococcal diseases) generally
spread throughout the community, from person to per-
son, through hand contact, respiratory route, or fecal-
oral route. During community epidemics, these
infections may be conveyed to hospital and transmitted
to hospitalized patients.
Hospital outbreaks of CDs have been increasingly
reported during the last decades and have had signifi-
cant consequences in terms of patient morbidity, mor-
tality, and associated costs [1,2]. Investigating and
analyzing series of hospital outbreaks help identifying
the sources of infection, the hosts’, and the environmen-
tal factors that promote these outbreaks [2,3] and pre-
venting the occurrence of additional cases; besides, these
studies increase the knowledge about the disease and
improve control measures to avoid future outbreaks. * Correspondence: nicolas.voirin@chu-lyon.fr
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ing an outbreak is mainly descriptive and the measures
of disease occurrence remain imprecise. When little
data are available, modeling of hospital-acquired infec-
tions relies on mathematical models to assess qualita-
tively the dynamics of CDs and the effects of control
measures [4,5]. Conversely, when observational data are
existing, it becomes possible to actually quantify the
effects. But quantitative studies need to take into
account the epidemiological process outside, the hospital
and host-related risk factors of infection and the role of
other patients and healthcare workers (HCWs) as
sources of infection. Because the risk of CD of a patient
in a unit of time depends on the number already
affected by the CD [6], a distinction between susceptibil-
ity and exposure to infection is required to correctly
estimate the risk of infection [7]. This may be achieved
by incorporating information related to exposure to
infection among the explanatory variables. Because
exposure to infection changes over time, exposure
changes should be treated as time-dependent variables.
Estimating parameters and the associated uncertainty is
important to answer epidemiological questions that are
specific to the hospital setting [4].
We propose here a subject-specific multiplicative
hazard regression model to analyze the risk of CD
among hospitalized patients. This model includes com-
munity CD incidence data and can be used to estimate
the relative effects of a stay in a specific hospital ward,
host factors and exposure to infection on the risk of
CD. Using influenza-like illness (ILI) data collected at
hospital during the 2004-2005 influenza season, the ana-
lysis shows how to apply the model to assess the risk of
ILI among hospitalized patients during community ILI
epidemics.
Methods
Model rationale
Once a CD has been imported at hospital, it may be of
interest to assess if, for a given patient, the risk of CD
at hospital differs from the risk of CD if this patient
would have stayed at home. For this, we adopted a
counterfactual approach and used observed data from
the community epidemics to estimate the relative risk
of CD at hospital compared to the community.
Because the risk of CD for a given patient may depend
on the ward he/she stayed, on his/her propensity to
acquire the CD and on how he/she is exposed to con-
tagious persons at hospital, the model also includes
such variables that are observed at hospital. Then, the
model allows 1) estimating the relative risk of CD at
hospital compared to the community and 2) studying
the hospital-, host- and exposure-related factors that
modulate this relative risk.
Model specifications
The proposed statistical model belongs to the class of
multiplicative hazard regression models. The risk of CD
at time t for a given patient i of age a with hospital-
related, host and exposure characteristics z can be mod-
eled as follows:
λ(ti,ai,zi) = λC(ti,ai)G(ti,zi).
In this model, lC(ti,ai) represents the expected risk of
CD at time t for that patient i in the community and G
(ti, zi) corresponds to hospital-, host- and exposure-
related effects associated with the elements of covariate
vector z for that patient i at time t. The hospital-, host-
and exposure-related effects act multiplicatively on the
risk of CDs. In the model, t denotes actual calendar
time with t = 0 being the date of start of the study
period.
Expected risk of CD in the community
The expected risk lC(ti,ai) is obtained from relevant
general-population diseases statistics using external
sources such as surveillance-based age-specific diseases
incidence rates. This approach is known as a counterfac-
tual approach in which the expected risk in the commu-
nity is defined as the risk among the same patients if
they have stayed at home. During the period of commu-
nity epidemics, hospitals are continuously exposed in
time to the risk of diseases imported from outside, so
that the expected hazard need to be indexed on time.
The confounding effect of age is taken into considera-
tion in lC(ti,ai) for the following reasons. First, young
children and elderly people are generally supposed to be
more susceptible to CDs than young and middle-aged
adults because the natural immunity and the resistance
to infection are associated with age. Second, young and
middle-aged adults are likely to be exposed to infectious
children in their households or to other infectious adults
with specific risks of CD [8-10]. Third, because vaccina-
tion coverage changes with age, different levels of
induced immunity to CDs are expected according to
age. All the former reasons led us to allow the model
controlling for age in the expected risk.
Hospital, host and exposure effects
We further assume that three hospital-related effects are
involved in G(ti, zi): 1) an effect associated with being at
hospital, 2) an effect associated with the observed sus-
ceptibility of the patient to infection when he/she is at
hospital, and 3) an effect associated with his/her
observed exposure to infectious persons met at hospital.
In the model, these effects are separately considered to
allow estimations of their relative contributions to the
risk of CD. These three effects at time t for a given
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with susceptibility characteristics s and exposure ψ up
to time t can be modeled as follows:
G(ti,xi,τi,si,ψi) = νH(ti,xi,τi)νS(ti,si)νE(ti,ψi).
Expression νH(ti,xi,τi) represents the effect of being at
hospital in ward x at time t for patient i admitted at
time τ.E x p r e s s i o nνS(ti,si) represents the effect asso-
ciated with the propensity of patient i to acquire a CD
according to his/her susceptibility characteristics s.
Finally, νE(ti,ψi) represents the effect of exposure
o b s e r v e da th o s p i t a l ,ψ,o fp a t i e n ti. These 3 effects are
supposed to act multiplicatively on the risk of CDs.
Each of these 3 model’s components is detailed below.
Written exclusively at the patient level, the following
formulas will no more mention index i.
Effect of being at hospital
When a patient is at hospital, several hospital-related
effects may change his/her risk of CD. First, he/she is
assumed to be isolated and partially protected. Second,
this potential protection may depend on the hospital
ward (e.g., surgery, intensive care unit, etc.). Third, his/
her risk may depend of the day of admission. The inter-
play of these three effects is modeled with νH.F o ra n
given patient admitted at time τ, the effect of being at
hospital in ward x may be modeled as follows:
νH(t,x,τ) = exp

β0 + βxxt +f ( t − τ)

where bx is the effect of being at time t in ward x, and
f(t-τ) the effect of the length of stay until time t on the
risk of CD. For example, f might be a polynomial
function.
Parameter b0 combines the effect of being at hospital
and the effects associated with patient’su n m e a s u r e d
susceptibility and unobserved exposure. All sources of
infection (patients, HCWs, or visitors) are usually imper-
fectly identified; thus, through b0,t h em o d e la l l o w s
transmission from unobserved or unobservable sources
such as symptomatic infectious persons unnoticed dur-
ing observation, asymptomatic infectious persons, or
asymptomatic carriers. Parameter b0 may be negative or
positive. A negative value can be interpreted as a
decrease in the risk of CD in hospital compared to the
community, due for example to isolation, whereas a
positive value can be interpreted as an increase in this
risk at hospital compared to the community, due for
instance to a higher unobserved exposure or a higher
susceptibility to infection at hospital.
Effect associated with observed susceptibility to CDs
Susceptibility characteristics can be added to the model
through νS(t, s) which represents the propensity of a
patient to acquire a CD when he/she is at hospital. For
a given patient, susceptibility characteristics measured
by covariate vector s at time t m a yb ei n c l u d e di nt h e
model using:
νS(t,s) = exp

β 
Sst

where bS is the vector of unknown coefficients to be
estimated and represents the effects of the elements of
covariate vector s acting multiplicatively on the risk of
CDs. Examples of susceptibility covariates are age at
admission, the presence of an immunodeficiency-related
disease, or the use of immunosuppressive drugs. Here,
age at admission is included in the hospital covariates to
capture effects associated with the care of an older
patient compared to a younger patient, which may be
associated to a different exposure to the risk of disease.
Effect associated with observed exposure at hospital
When a patient is at hospital, he/she becomes poten-
tially exposed to infectious persons within the institu-
tion. The effect of hospital exposure a given patient at
time t can be modeled by:
νE(t,ψ) =exp

ψ(t)

where ψ(t) represents the observed exposure to infec-
tious persons at hospital.
To define exposures compatible with a transmission,
we assume a maximum incubation period of the CD of J
days. Then, exposure of a patient can be defined as the
presence in the same ward of an infectious person dur-
ing the J-day period preceding t. During the period of
exposure to an infectious patient or HCW, transmission
of CD is possible by direct contact, indirect contact, and
airborne transmission, whatever the relative importance
of each transmission mode. Infected persons remain
infectious for a given period and in the following, we
assumed a maximum infectious period of K-day.
At hospital, patients may be exposed to infectious
patients and infectious HCW and for a given patient,
exposure observed within hospital at time t can be writ-
ten as follow:
ψ(t) = βPPt + βHHt
where Pt (or Ht) take value 1 if the patient is exposed
to at least one identified infectious patient (or HCW)
during period [t - J; t - 1] and value 0 otherwise. Here,
bP and bH represent the effects of observed exposure at
hospital to infectious patients (Pt = 1) or infectious
HCWs (Ht = 1). The model is written with exposure to
infectious patients or infectious HCWs, but other
sources of infection, such as infectious visitors, can be
included in the same way.
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The method of estimation uses a standard manipulation
for estimating the parameters of a multiplicative hazard
model, by discretization of the time scale and recasting
the estimation within the context of Poisson regression
[11,12]. It approximates the contribution of each patient
to the full log-likelihood by a sum of Poisson terms on
time intervals that are sufficiently small for the assump-
tion of a constant rate to be acceptable. Usually, at our
hospital, patients are admitted in the afternoon and dis-
charged in the morning. HCWs work either in the
morning or the afternoon; thus, a half-day was consid-
ered as the width of the time interval. Within a half-day,
the effects of exposure to infection and other covariates
can be assumed constant. The likelihood can be consid-
ered as deriving from a generalized linear model with
the outcome “diseased or not” ( i . e .1o r0 ) ,aP o i s s o n
distribution function, a log-link function and log(lC(ti,
ai)) as an offset. Patients participated to the risk set
since the half-day of admission at hospital and follow-
u pw a sc e n s o r e da td i s c h a r g eo ra tt h et i m eo fC D
onset.
Data on influenza-like illness used for application
The data originated from 3 sources. The first source is a
prospective observational study carried out between
November 15, 2004 to April 15, 2007 at Edouard Her-
riot Hospital in Lyon, France [13]. A total of 36 adult
short-stay units participated on a voluntary basis, 12
with 224 beds in 2004-05, 29 with 493 beds in 2005-06,
and 30 with 537 beds in 2006-07. During the study,
each participating ward was daily followed-up to detect
ILI cases; i.e., patients or HCWs presenting with fever
(≥ 37.8°C) and cough or sore throat. A non-case was
defined as a patient or a HCW free from ILI during the
study period. For each case, demographic, medical, and
hospitalization data as well as clinical observations
related to ILI were recorded through a questionnaire
administered by a member of the infection control
team. However, only the date of ILI onset for each case
was considered here. Patients presenting with ILI at
admission were excluded from the analysis, assuming
they were not at risk of hospital-acquired ILI. Patients
participated to the risk set since the half-day of admis-
sion at hospital and follow-up was censored at discharge
or at the time of ILI onset (i.e. assuming patients were
no more at risk of ILI). A patient re-admitted at hospital
participated again to the risk set except if he or she pre-
sented ILI during a previous stay or at the time of re-
a d m i s s i o n .F o rt h ep r e s e n ta n a l y s i s ,o n l yd a t af r o mt h e
season 2004-05 (12 wards) were used. The hospital insti-
tutional review board approved the study. All ILI cases
(patients and HCWs) received printed information and
signed an informed consent form.
As second source, all hospital data (admission and dis-
charge dates, place and immunodeficiency-related diag-
noses) of cases and non-cases were extracted from the
hospital’s information system. Data on periods of work
for HCWs were included.
The third source comprised community data on the
number of ILI incident cases available from the
national surveillance network [14]. These are estima-
tions of the weekly numbers of new ILI cases in the
Rhône-Alpes population grouped by 5-year age cate-
gories. The data were completed with regional popula-
tion figures by 5-year age strata obtained from the
INSEE (Institut National de la Statistique et des Études
Économiques).
We calculated weekly ILI incidence rate in the
Rhône-Alpes region by age group by dividing the
weekly number of new ILI cases in the Rhône-Alpes
region by the Rhone-Alpes population figures. Inci-
dence rates of ILI from the community population
were then applied week by week to the age structure
of the patients’ population (i.e. using indirect standar-
disation) to calculate lC (t,a).
Over a total of 56,826 half-days (4,059 weeks) of fol-
low-up, 24 incident cases of ILI were observed among
4,484 patients at risk of ILI. The incidence rate of ILI at
hospital was 5.91 (95% confidence interval (95% CI)
3.96-8.82) per 1,000 patient-weeks.
Model applications
In this section and based on the data presented in the
previous section, we present how the model can be used
to assess the risk of ILI among hospitalized patients dur-
ing community ILI epidemics. The following analysis
was performed:
1. Effect of being at hospital. To investigate whether
the risk of ILI in hospitalized patients was higher
than their expected risk in the community, the fol-
lowing model form was used:
λ(t,a) = λC(t,a)νH
with νH =e x p ( b0) representing, for a given patient at
time t, the hazard ratio (HR) of acquiring ILI at hospital
vs. in the community.
To further studied whether the specialty of the wards
might affect the risk of ILI, the model can be modified
as follows:
λ(t,a,x) = λC(t,a)νH(t,xt)
with νH(t,xt)=e x p ( b0 + bxxt)a n dxt being a variable
with 4 categories; one for each specialty of the ward (i.e.
surgery, medical care, gynecology and intensive care)
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2. Effect associated with observed susceptibility to ILI.
To examine how sex, age at admission, and impaired
immune status might modify the risk of ILI, the
model was written as follows:
λ(t,a,s) = λC(t,a)νHνS(t,st)
with νH = exp(b0) and, for a given patient at time t, νS
(t, s)=e x p ( b
’
Sst)w h e r es is the vector of covariates
representing sex (male, female), age at admission (18-34,
35-64, and ≥ 65 years old) and impaired immune status
(yes, no).
3. Effect associated with observed exposure at hospi-
tal.T oi n v e s t i g a t eh o we x p o s u r et oi n f e c t i o u s
patients and/or HCWs may affect the patients’ risk
of ILI, we assumed a maximum incubation period of
ILI of J = 5 days [15] and a maximum infectious per-
iod of ILI of K = 6 days starting one day before
symptom onset [15]. We used the following model:
λ(ti,ai,ψi) = λC(ti,ai)νHνE(ti,ψi)
with νH =e x p ( b0) and, for a given patient at time t, νE
(t,ψ)=e x p( ψ(t)) with ψ(t)=bPPt + bHHt + bPHPHt.
The variables Pt and Ht represent the presence of at
least one infectious patient or one infectious HCW,
respectively, in the 5 days preceding t. The variable PHt
represented the simultaneous presence of at least one
infectious patient, Pt, and at least one infectious HCW,
Ht, in the 5 days preceding t.
We present estimations for the 4 separate models.
Modelling was done using a strategy of selecting vari-
ables based on epidemiological knowledge and no actual
model selection based on significance was done. For our
application, November 15, 2004 (week 47) was the start-
ing time (t = 0).
Results
Effect of being at hospital
The weekly incidence rates noted at hospital l(t)a n d
expected in the community lC (t,a) are shown in Figure
1. The graph suggested comparing the areas under the 2
curves, providing a way to investigate whether being at
hospital modulated the patients’ expected risk of ILI.
During the study period, 24 cases were observed at hos-
pital and 18.07 cases were expected among the 4,484
patients if they have stayed at home.
The HR of acquiring ILI at hospital vs. in the commu-
nity was νH = 1.33 (95% CI: 0.89-1.98, p = 0.16) which
suggested, despite the lack of statistical significance, that
during the study period the risk of acquiring ILI would
be higher at hospital than in the community.
We further studied whether the specialty of the wards
might affect the risk of ILI. Twelve hospital wards, dis-
tributed in 4 specialties, participated in the study (Table
1).
Heterogeneity of the risk of ILI between specialties
was assessed by comparing the deviances of the models
with vs. without νH(t,xt). The deviance was 31.83 for 3
degrees of freedom (p < 0.01), indicating that the risk of
ILI differed among specialties.
Compared to medical wards, the HR of ILI was 0.10
(95% CI 0.01-0.78, p = 0.03) for surgery and 0.04 (95%
CI 0.01-0.32, p < 0.01) for gynecology; i.e., a significantly
lower risk of ILI was observed in surgery and gynecol-
ogy units compared to medical units.
Effect associated with observed susceptibility to ILI
Being a female did not significantly affect the adjusted
HR of ILI (2.03, 95% CI: 0.82-5.02, p = 0.13). Compared
to that of the 18-34 years age category, the HR for ages
35-64 and ≥ 65 years were 4.04 (95% CI: 0.78-20.82, p =
0.10) and 14.35 (95% CI: 3.09-66.69, p < 0.01), respec-
tively, indicating an increase in the risk of ILI with age
at admission. Compared to less susceptible patients,
those with impaired immunity had a HR of ILI of 1.47
(95% CI: 0.63-1.44, p = 0.37).
Effect associated with observed exposure at hospital
The results are reported in Table 2 and suggest that
being exposed to infectious patients, infectious HCWs
or both significantly increases the risk of ILI compared
to the absence of proven source of infection at hospital.
Discussion
The multiplicative hazard regression model developed
here allows assessing the risk of CDs among hospitalized
patients. This model can be used to quantify the risk of
CD at hospital according to three axes: i) explore
whether the risk of CD at hospital differs from the one
in the community and whether there is heterogeneity
among wards; ii) identify host factors facilitating CDs;
iii) identify the main routes of CD transmission at
hospital.
The application of that model to ILI integrates simul-
taneously information on community ILI epidemics,
hospital wards, susceptibility to the disease, and expo-
sures occurring at hospital. In this application, it was
shown that being hospitalized might increase the
patient’s risk of ILI compared to the community, that
significantly higher risks were observed in medical
wards than in other specialty wards, and that infectious
patients may represent an important route of transmis-
sion to other patients.
Identifying at risk hospital areas, high risk groups of
patients, and primary interventions according to the
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managing and efficiently controlling person-to-person
spread of CDs at hospital. Some wards may present high
risks of CDs while others might be rather protective.
Identifying the latter is important to isolate specific
patients such as the immunosuppressed ones. In fact,
the functioning of a ward (e.g., specialty, infection con-
trol measures, vaccination coverage of patients and
HCWs, distance between beds, availability of hand-
washing materials for staff, etc.) rather than its location
is probably of interest. Identifying and comparing the
routes of transmission could help define and prioritize
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Figure 1 Observed risk of ILI l(t) and expected risk of ILI lC(t,a) during influenza season 2004-2005.
Table 1 Numbers of ILI cases observed at hospital and expected in the community according to the ward and its
medical specialty.
Ward Specialty Number of observed ILI cases at
hospital
Number of ILI cases expected in the
community
Number of half-days of hospital
stay
By ward By specialty By ward By specialty By ward By specialty
W169 Surgery 1 1 1.43 2.96 4,587 9,320
W227 Surgery 0 1.53 4,733
W109 Medical care 1 22 0.78 6.82 2,541 27,104
W113 Medical care 1 0.78 2,586
W117 Medical care 1 1.80 5,842
W230 Medical care 1 1.55 5,675
W245 Medical care 6 1.15 5,006
W292 Medical care 12 0.76 5,454
W235 Gynecology 0 1 3.71 7.15 8,376 16,289
W236 Gynecology 0 2.11 4,918
W237 Gynecology 1 1.33 2,995
W134 Intensive care 0 0 1.15 1.15 4,113 4,113
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the visits, avoiding contact between susceptible patients
and infectious persons, or isolating infectious persons
(patients or HCWs) to protect patients, especially the
more susceptible ones.
Some statistical approaches have been proposed to
model infectious diseases data in a regression framework
[16-18] providing often a simple method making use of
existing software. In addition, some hospital-, ward- and
subject-specific approaches have been proposed
[17,19-23] to analyze hospital infection data. However,
compared to these approaches, the model presented
here is, to our knowledge, among the first to include
simultaneously the specificities of the hospital setting,
namely ward heterogeneity, host-factor susceptibility
and separated patients and HCWs exposures. This
allows estimating separately these effects. More specifi-
cally, the epidemiological process outside, which may
influence the epidemiological process inside, is explicitly
taken into account in our model using known data on
t h er i s kd u et oac i r c u l a t i o no ft h ed i s e a s ei nt h e
community.
Due to the high fluctuations in the number of patients
(admission and discharge), of HCWs work hours and of
HCWs and patients exposure, subject-specific models
may be preferred for hospital outbreak modeling. In our
model, exposure was defined, at the patient level and for
each day of hospitalization, as the presence of an infec-
tious person in the same ward during the days preced-
ing time t. Within the context of CDs it seems more
appropriate to consider exposure rather than contact
because it is not easy to determine which contact
among many led to the infection. This definition
includes all types of disease transmission and may be
refined according to the studied pathogen.
However, the model assumptions may limit its scope.
If each person included in the study could be individu-
ally followed-up, it would be possible to know who con-
tacted whom, where, when, and for how much time.
The model assumes that the number of contacts during
exposure was sufficient to induce infection, which may
not be the case because the contacts were not observed.
Each hospital outbreak is unique, with specific events
leading to the epidemic. Thus, the results of a single
epidemic should not be generalized to other contexts.
However, the model could be a valuable tool for evalu-
ating and comparing outbreaks between years in the
same area. Besides, there was a discrepancy between the
model presented in its most general form and the data
that may not have been rich enough to demonstrate
simultaneously all its features. The low number of inci-
dent events (only 24 ILIs) did not allow estimating all
the parameters linked with hospital-related variables,
susceptibility, and exposure. It could be interesting to
apply the model to a larger dataset.
Conclusions
The proposed multiplicative hazard regression model
could be an interesting epidemiological tool to identify
key epidemiological, environmental, host, or exposure
factors that increase or decrease the risk of CD in other
confined settings such as kindergartens, schools, work-
places or day-care facilities where individuals and groups
interact closely. In the hospital setting, this model could
be a valuable tool to assess the risk of CD among
patients in order to improve everyday infection control
and management of local outbreaks.
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1 0.30 4.44 (0.58-34.18) 0.15
At least 1 infectious patient but no
infectious HCW
7 1.26 7.42 (2.92-28.84) < 0.01
At least 1 infectious HCW and 1
infectious patient
4 0.50 10.63 (3.43-32.95) < 0.01
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